Liquidia Corporation (NASDAQ:LQDA – Get Free Report) Director Stephen Bloch sold 145,954 shares of Liquidia stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $65.58, for a total value of $9,571,663.32. Following the sale, the director directly owned 1,418,453 shares of the company’s stock, valued at $93,022,147.74. This represents a 9.33% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
Liquidia Stock Down 0.6%
LQDA opened at $71.23 on Friday. Liquidia Corporation has a fifty-two week low of $11.85 and a fifty-two week high of $72.71. The company has a debt-to-equity ratio of 1.18, a quick ratio of 2.03 and a current ratio of 2.22. The company has a market capitalization of $6.33 billion, a P/E ratio of 508.82 and a beta of 0.58. The stock has a fifty day moving average of $49.85 and a 200-day moving average of $40.89.
Liquidia (NASDAQ:LQDA – Get Free Report) last posted its earnings results on Monday, May 11th. The company reported $0.52 earnings per share for the quarter, topping analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The company had revenue of $132.87 million during the quarter, compared to the consensus estimate of $119.44 million. The business’s quarterly revenue was up 4187.1% compared to the same quarter last year. On average, equities analysts expect that Liquidia Corporation will post 2.97 EPS for the current year.
Analyst Upgrades and Downgrades
Get Our Latest Stock Report on Liquidia
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of LQDA. Northwestern Mutual Wealth Management Co. acquired a new position in Liquidia during the fourth quarter worth about $25,000. NewEdge Advisors LLC acquired a new position in Liquidia during the second quarter worth about $25,000. Skandinaviska Enskilda Banken AB publ acquired a new position in Liquidia during the third quarter worth about $30,000. FNY Investment Advisers LLC acquired a new position in Liquidia during the third quarter worth about $34,000. Finally, Covestor Ltd raised its stake in Liquidia by 41.9% during the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after acquiring an additional 359 shares in the last quarter. Institutional investors and hedge funds own 64.54% of the company’s stock.
Liquidia Company Profile
Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.
The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).
Read More
- Five stocks we like better than Liquidia
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
